Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps

PURPOSE: To evaluate the 12-month outcome of anti-vascular endothelial growth factor (VEGF) treatment for extrafoveal polypoidal choroidal vasculopathy (PCV). METHODS: This retrospective observational study included 32 eyes of 32 patients newly diagnosed with extrafoveal PCV (polyps located more tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jae Hui, Lee, Dong Won, Choi, Sung Chan, Kim, Jong Woo, Lee, Tae Gon, Kim, Chul Gu, Cho, Han Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Ophthalmological Society 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668256/
https://www.ncbi.nlm.nih.gov/pubmed/26635457
http://dx.doi.org/10.3341/kjo.2015.29.6.404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668256/
https://www.ncbi.nlm.nih.gov/pubmed/26635457
http://dx.doi.org/10.3341/kjo.2015.29.6.404

Ejemplares similares